Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose
Corrado Pelaia(Azienda Ospedaliero Universitario Mater Domini), Girolamo Pelaia(Magna Graecia University), Alessandro Vatrella(University of Salerno), Giuseppe Rago(Magna Graecia University), Maria Teresa Busceti(Magna Graecia University), Rosa Terracciano(Magna Graecia University), Claudia Crimi(Marconi University)
Cited by 62
Related Papers
A European survey of noninvasive ventilation practices
|European Respiratory Journal|2010|205
Determinants of tracheostomy decannulation: an international survey
|Critical Care|2008|177
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
|Frontiers in Pharmacology|2022|157
Molecular Targets for Biological Therapies of Severe Asthma
|Frontiers in Immunology|2020|132